SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-042106
Filing Date
2023-02-17
Accepted
2023-02-17 17:11:56
Documents
5
Period of Report
2023-04-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A d456007dpre14a.htm PRE 14A 193760
2 GRAPHIC g456007g54q26.jpg GRAPHIC 44672
3 GRAPHIC g456007g54q27.jpg GRAPHIC 27096
4 GRAPHIC g456007g54q28.jpg GRAPHIC 182921
5 GRAPHIC g456007g54q29.jpg GRAPHIC 155118
  Complete submission text file 0001193125-23-042106.txt   751873
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36352 | Film No.: 23643962
SIC: 2834 Pharmaceutical Preparations